5Suppliers
19Customers
2Debt Items
20Related Chains

Source-Backed Evidence Depth

Labcorp Holdings Inc. (LH) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

27Total relationships
3Distinct source URLs
10High confidence
0.741Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Labcorp Holdings Inc. Suppliers

TickerNameConfidenceEvidence
IDXG Interpace Biosciences, Inc. 92% Reciprocal relationship from IDXG graph: Our largest customer in 2025 for ThyGeNEXT ® and ThyraMIR ® v2 was Laboratory Corporation of America ® or LabCorp. | Qwen verified: Explicit commercial relati…
LABCORP-RECEIVABLES-LLC LABCORP-RECEIVABLES-LLC 92% Labcorp Receivables is a separate legal entity with its own separate creditors who will be entitled to access Labcorp Receivables assets before the assets become available to the Company.
PNC-BANK-NATIONAL-ASSOCIATION PNC-BANK-NATIONAL-ASSOCIATION 90% PNC Bank, National Association, as administrative agent and the other parties thereto
VENDOR VENDOR 90% The Company has a noncancelable contract with a vendor to purchase supplies inventory pursuant to which the Company is obligated to make expected total future minimum payments of $122.3
FTRE Fortrea Holdings Inc. 72% Reciprocal relationship from FTRE graph: Reciprocal relationship from LH graph: Reciprocal relationship from FTRE graph: Reciprocal relationship from LH graph: Reciprocal relationship from FTRE graph…

Labcorp Holdings Inc. Customers

TickerNameConfidenceEvidence
PHARMACEUTICAL-BIOTECHNOLOGY-AND-MEDICAL-DEVICE- PHARMACEUTICAL-BIOTECHNOLOGY-AND-MEDICAL-DEVICE- 92% BLS Pharmaceutical, biotechnology and medical device companies 9 % 9 % 4 % 22 % 10 % 9 % 4 % 23 % Total revenues 87 % 9 % 4 % 100 % 87 % 9 % 4 % 100 %
LABCORP-RECEIVABLES LABCORP-RECEIVABLES 85% collections from the receivables in excess of amounts required to repay the Purchasers and other creditors of Labcorp Receivables may be remitted to the Company
PARKVIEW-HEALTH-SYSTEM-INC PARKVIEW-HEALTH-SYSTEM-INC 85% quisitions $ 165.0 $ 37.2 $ — $ 202.2 Intangible assets recognized from business acquisitions that closed during the three months ended March 31, 2026, including any related measurement period adjust…
FTRE Fortrea Holdings Inc. 72% Reciprocal relationship from FTRE graph: Reciprocal relationship from LH graph: Reciprocal relationship from FTRE graph: Reciprocal relationship from LH graph: ted to the continued impact of COVID-19…
FTRE Fortrea Holdings Inc. 72% ted to the continued impact of COVID-19; and other events beyond the Company's control; 33. discontinuation or recalls of existing products used in the performance of testing; 34. a failure in the Co…
TD The Toronto-Dominion Bank 72% Reciprocal relationship from TD graph: Reciprocal relationship from LH graph: Reciprocal relationship from TD graph: Reciprocal relationship from LH graph: edit facility, the Company is subject to ne…
TD The Toronto-Dominion Bank 72% edit facility, the Company is subject to negative covenants limiting subsidiary indebtedness and certain other covenants typical for investment grade-rated borrowers and the Company is required to ma…
AMERICA-HOLDINGS AMERICA-HOLDINGS 62% ) address. For the individuals whose Social Security Number was affected, the notice included an offer to enroll in credit monitoring and identity protection services that was provided free of charge…
BAYSTATE-MEDICAL-CENTER-PROVIDENCE-MEDICAL-FOUND BAYSTATE-MEDICAL-CENTER-PROVIDENCE-MEDICAL-FOUND 62% risk for specific biotechnology receivable balances. F-19 Index LABCORP HOLDINGS INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Dollars and shares in millions, except per share dat…
BEACON-LABORATORY-BENEFIT-SOLUTIONS-INC BEACON-LABORATORY-BENEFIT-SOLUTIONS-INC 62% $ 423.3 Dispositions During the year ended December 31, 2024, the Company sold the assets of its Beacon Laboratory Benefit Solutions, Inc. for $ 13.5 and recorded a gain of $ 6.4 . F-20 Index LABCORP…
EMPIRE-CITY-LABORATORIES-INC EMPIRE-CITY-LABORATORIES-INC 62% . Total consideration includes cash payments and, as applicable, contingent consideration payable by the Company primarily upon the achievement of specified future performance targets of the acquired…
FACEBOOK-IRELAND-LIMITED FACEBOOK-IRELAND-LIMITED 62% an inspection report documenting the deficiencies and setting deadlines for any required corrective actions. The USDA may impose fines, suspend and/or revoke licenses and registrations, or confiscate…
LABCORP-HOLDINGS LABCORP-HOLDINGS 62% ng from errors or omissions in the performance of testing and other services or other contractual arrangements; 22. changes or disruption in the provision or transportation of services or supplies pr…
MUFG-BANK-LTD MUFG-BANK-LTD 62% edit facility, the Company is subject to negative covenants limiting subsidiary indebtedness and certain other covenants typical for investment grade-rated borrowers and the Company is required to ma…
NOMINAL-DEFENDANT-LABORATORY-CORPORATION NOMINAL-DEFENDANT-LABORATORY-CORPORATION 62% ) address. For the individuals whose Social Security Number was affected, the notice included an offer to enroll in credit monitoring and identity protection services that was provided free of charge…
PRELIMINARY-PERSONAL-GENOME-DIAGNOSTICS-INC PRELIMINARY-PERSONAL-GENOME-DIAGNOSTICS-INC 62% — — — — — ( 2.3 ) ( 2.3 ) Other liabilities — — — — — ( 4.1 ) — ( 4.1 ) Total liabilities acquired — — 3.9 — — ( 1.7 ) ( 10.6 ) ( 8.4 ) Net assets acquired $ 110.2 $ 112.8 $ 110.0 $ 157.0 $ 107.7 $ 7…
RETRIEVAL-MASTERS-CREDITORS-BUREAU-INC RETRIEVAL-MASTERS-CREDITORS-BUREAU-INC 62% l 9, 2026 , the Company announced a cash dividend of $ 0.72 per share of Common Stock, or approximately $ 60.0 in the aggregate. The dividend will be paid on June 11, 2026 , to stockholders of record…
U-S-BANK-TRUST-COMPANY U-S-BANK-TRUST-COMPANY 62% ng from errors or omissions in the performance of testing and other services or other contractual arrangements; 22. changes or disruption in the provision or transportation of services or supplies pr…
WESTPAC-LABS-INC WESTPAC-LABS-INC 62% risk for specific biotechnology receivable balances. F-19 Index LABCORP HOLDINGS INC. AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Dollars and shares in millions, except per share dat…

Labcorp Holdings Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
LH-DEBT-10699 Xbrl Convertible 90% xbrl convertible detail from xbrl 2017-09-30.
LH-DEBT Debt stack $6.9B 90% Market cache reports total debt of $6.9B.

Labcorp Holdings Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Labcorp Holdings Inc..

Labcorp Holdings Inc. Ownership

HolderNameConfidenceEvidence
LH-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC VANGUARD CAPITAL MANAGEMENT LLC 90% 13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 1021 tracked holders.

Labcorp Holdings Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
NFG National Fuel Gas Company 100.00 2
ACGL Arch Capital Group Ltd. 100.00 2
IDXG Interpace Biosciences, Inc. 100.00 1 ['supplier']
FISV Fiserv, Inc. 100.00 2
ROP Roper Technologies, Inc. 100.00 2
CAPS Capstone Holding Corp. 100.00 2
FHI Federated Hermes, Inc. 50.00 2
VRSK Verisk Analytics, Inc. 50.00 2
APPN Appian Corporation 50.00 2
DGX Quest Diagnostics Incorporated 50.00 2
CEPV Cantor Equity Partners V, Inc. 50.00 2
CEPF Cantor Equity Partners IV, Inc. 50.00 2
CAEP Cantor Equity Partners III, Inc. 50.00 2
SGOL abrdn Physical Gold Shares ETF 50.00 2
SCAG Scage Future 50.00 2
PRPH ProPhase Labs, Inc. 50.00 2
QGEN Qiagen N.V. 50.00 2
IQV IQVIA Holdings Inc. 50.00 2
FHN First Horizon Corporation 50.00 2
TGT Target Corporation 50.00 2
🔐
LH
Unlock LH Supply Chain Data
Verified relationships include:
IDXGInterpace Biosciences, Inc.Supplier92%
LABCORP-RECEIVABLES-LLCLABCORP-RECEIVABLES-LLCSupplier92%
PHARMACEUTICAL-BIOTECHNOLOGY-AND-MEDICAL-DEVICE-PHARMACEUTICAL-BIOTECHNOL…Customer92%
LABCORP-RECEIVABLESLABCORP-RECEIVABLESCustomer85%
+23 more relationships locked
Subscribe — View plans →